Fazer Bakeries Ltd.   Report issue

For profit Phase 2
Founded: Vantaa Finland (1891)
Status: No NME R&D (1891)

Organization Overview

First Clinical Trial
2008
NCT01084226
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Fazer Bakeries | Fazer Group

Active Ingredients

Drugs in Phase 2 Trials (1)

rye kernel (1 trial)

Drugs in Other Trials (3)

bilberry (1 trial)

dark chocolate (1 trial)

prulifloxacin (1 trial)

Indications

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 4